A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
AKER BIOMARINE ASA operates in the Packaged Foods industry, Consumer Defensive sector. Full business description from SEC filing not yet available.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 199M | 199M | 196M | 277M | 262M | 289M |
| Net Income | 0 | - | -9.0M | 10M | -8.0M | -5.5M |
| EPS | $-0.16 | $-0.16 | $-0.36 | $0.11 | $-0.09 | $-0.07 |
| Free Cash Flow | -5.2M | -5.2M | 1.5M | -25M | -76M | -73M |
| ROIC | -3.2% | -1.0% | -1.1% | 2.5% | -1.7% | 0.9% |
| Gross Margin | 34.7% | 34.7% | 36.9% | 41.4% | 33.6% | 38.0% |
| Debt/Equity | 0.00 | 0.85 | 1.07 | 0.90 | 0.84 | 0.69 |
| Dividends/Share | $0.00 | - | - | - | - | $1.24 |
| Operating Income | -6.5M | -6.5M | -10M | 22M | -14M | 7.0M |
| Operating Margin | -3.3% | -3.3% | -5.3% | 8.0% | -5.2% | 2.4% |
| ROE | 0.0% | - | -2.4% | 2.7% | -2.2% | -1.5% |
| Shares Outstanding | 0M | - | 25M | 91M | 89M | 78M |
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 289M | 262M | 277M | 196M | 199M | 199M |
| Gross Margin | 38.0% | 33.6% | 41.4% | 36.9% | 34.7% | 34.7% |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | -87M | -86M | -87M | -66M | -61M | -61M |
| EBIT | 7.0M | -14M | 22M | -10M | -6.5M | -6.5M |
| Op. Margin | 2.4% | -5.2% | 8.0% | -5.3% | -3.3% | -3.3% |
| Net Income | -5.5M | -8.0M | 10M | -9.0M | N/A | 0 |
| Net Margin | -1.9% | -3.1% | 3.6% | -4.6% | N/A | 0.0% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | ||||||
| ROIC | 0.9% | -1.7% | 2.5% | -1.1% | -1.0% | -3.2% |
| ROE | -1.5% | -2.2% | 2.7% | -2.4% | N/A | 0.0% |
| ROA | -0.8% | -1.1% | 1.3% | -1.1% | N/A | 0.0% |
| Cash Flow | ||||||
| Op. Cash Flow | -51M | 2.6M | 15M | 47M | 12M | 12M |
| Free Cash Flow | -73M | -76M | -25M | 1.5M | -5.2M | -5.2M |
| Owner Earnings | -99M | -50M | -36M | -4.9M | -36M | -36M |
| CapEx | 22M | 79M | 41M | 46M | 17M | 17M |
| Maint. CapEx | 48M | 53M | 51M | 52M | 48M | 48M |
| Growth CapEx | 0 | 26M | 0 | 0 | 0 | 0 |
| D&A | 48M | 53M | 51M | 52M | 48M | 48M |
| CapEx/OCF | N/A | 3026.9% | 268.2% | 96.8% | 142.6% | 142.6% |
| Capital Allocation | ||||||
| Dividends Paid | 97M | 0 | 0 | 0 | 373M | 373M |
| Dividend Yield | 1.3% | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Stock-Based Comp | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 | 0 |
| Balance Sheet | ||||||
| Net Debt | 246M | 299M | 317M | 366M | 133M | -15M |
| Cash & Equiv. | 11M | 11M | 22M | 28M | 15M | 15M |
| Long-Term Debt | N/A | N/A | N/A | 344M | 140M | 140M |
| Debt/Equity | 0.69 | 0.84 | 0.90 | 1.07 | 0.85 | 0.00 |
| Interest Coverage | 0.3 | -0.9 | 1.0 | -0.5 | -0.6 | -0.6 |
| Equity | 373M | 371M | 379M | 367M | 174M | 174M |
| Total Assets | 700M | 758M | 822M | 827M | 387M | 387M |
| Total Liabilities | 327M | 387M | 444M | 461M | 214M | 214M |
| Intangibles | N/A | N/A | N/A | N/A | N/A | N/A |
| Retained Earnings | -196M | -204M | -194M | -203M | -396M | -396M |
| Working Capital | 152M | 162M | 194M | 177M | 149M | 149M |
| Current Assets | 223M | 240M | 299M | 290M | 202M | 202M |
| Current Liabilities | 71M | 77M | 105M | 113M | 53M | 53M |
| Per Share Data | ||||||
| EPS | -0.07 | -0.09 | 0.11 | -0.36 | -0.16 | -0.16 |
| Owner EPS | -1.27 | -0.57 | -0.40 | -0.20 | N/A | N/A |
| Book Value | 4.78 | 4.17 | 4.17 | 14.66 | N/A | 0.00 |
| Cash Flow/Share | -0.65 | 0.03 | 0.17 | 1.90 | N/A | 0.00 |
| Dividends/Share | 1.24 | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 78.0M | 88.9M | 90.9M | 25.0M | N/A | 0.0M |
| Valuation | ||||||
| P/E Ratio | N/A | -573.3 | 334.1 | -120.8 | -410.6 | -675.0 |
| P/FCF | N/A | N/A | N/A | 725.0 | N/A | N/A |
| EV/EBIT | N/A | N/A | 165.5 | N/A | N/A | N/A |
| Price/Book | 23.8 | 12.4 | 8.8 | 3.0 | N/A | N/A |
| Price/Sales | 30.7 | 17.5 | 12.1 | 5.5 | N/A | N/A |
| FCF Yield | -0.8% | -1.7% | -0.8% | 0.1% | N/A | N/A |
| Market Cap | 8.9B | 4.6B | 3.3B | 1.1B | 0 | 0 |
| Avg. Price | 95.26 | 74.25 | 47.04 | 39.77 | 66.82 | 108.00 |
| Year-End Price | 113.64 | 51.60 | 36.75 | 43.50 | 65.70 | 108.00 |
AKER BIOMARINE ASA passes 0 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average gross margin is 36.9%. At current prices, the estimated annualized return to fair value is +6.1%.
AKER BIOMARINE ASA (AKBM-OL) has a 5-year average return on invested capital (ROIC) of -0.1%. This is below average and may indicate limited pricing power.
AKER BIOMARINE ASA (AKBM-OL) does not currently pay a regular dividend.
AKER BIOMARINE ASA (AKBM-OL) operates in the Packaged Foods industry, within the Consumer Defensive sector.
AKER BIOMARINE ASA (AKBM-OL) reported annual revenue of $199 million in its most recent fiscal year, based on SEC EDGAR filings.
AKER BIOMARINE ASA (AKBM-OL) generated $-5 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
AKER BIOMARINE ASA (AKBM-OL) has a debt-to-equity ratio of 0.85. This indicates moderate leverage.
AKER BIOMARINE ASA (AKBM-OL) reported earnings per share (EPS) of $-0.16 in its most recent fiscal year.
AKER BIOMARINE ASA (AKBM-OL) has a 5-year average gross margin of 36.9%. This indicates decent pricing power.
The Ledger Terminal provides 5 years of financial data for AKER BIOMARINE ASA (AKBM-OL), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
No recent press releases.